Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 173

1.

Lipid advanced glycosylation: pathway for lipid oxidation in vivo.

Bucala R, Makita Z, Koschinsky T, Cerami A, Vlassara H.

Proc Natl Acad Sci U S A. 1993 Jul 15;90(14):6434-8.

2.

Hydroxyalkenal formation induced by advanced glycosylation of low density lipoprotein.

Al-Abed Y, Liebich H, Voelter W, Bucala R.

J Biol Chem. 1996 Feb 9;271(6):2892-6.

3.

Evaluation of some biochemical changes in diabetic patients.

Abou-Seif MA, Youssef AA.

Clin Chim Acta. 2004 Aug 16;346(2):161-70.

PMID:
15256317
4.

What is the effect of hyperglycemia on atherogenesis and can it be reversed by aminoguanidine?

Bucala R.

Diabetes Res Clin Pract. 1996 Feb;30 Suppl:123-30. Review.

PMID:
8964186
6.

An agent cleaving glucose-derived protein crosslinks in vitro and in vivo.

Vasan S, Zhang X, Zhang X, Kapurniotu A, Bernhagen J, Teichberg S, Basgen J, Wagle D, Shih D, Terlecky I, Bucala R, Cerami A, Egan J, Ulrich P.

Nature. 1996 Jul 18;382(6588):275-8.

PMID:
8717046
7.

Hyperketonemia (acetoacetate) increases the oxidizability of LDL + VLDL in Type-I diabetic patients.

Jain SK, McVie R, Jaramillo JJ, Chen Y.

Free Radic Biol Med. 1998 Jan 1;24(1):175-81.

PMID:
9436628
8.

Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency.

Bucala R, Makita Z, Vega G, Grundy S, Koschinsky T, Cerami A, Vlassara H.

Proc Natl Acad Sci U S A. 1994 Sep 27;91(20):9441-5.

9.

Associations of LDL size with in vitro oxidizability and plasma levels of in vivo oxidized LDL in Type 2 diabetic patients.

Scheffer PG, Bos G, Volwater HG, Dekker JM, Heine RJ, Teerlink T.

Diabet Med. 2003 Jul;20(7):563-7.

PMID:
12823238
10.

The role of oxidative stress in the long-term glycation of LDL.

Menzel EJ, Sobal G, Staudinger A.

Biofactors. 1997;6(2):111-24.

PMID:
9259992
11.

Reduced susceptibility to oxidation of low-density lipoprotein in patients with overproduction of nitric oxide (Bartter's and Gitelman's syndrome).

Calò L, Sartore G, Bassi A, Basso C, Bertocco S, Marin R, Zambon S, Cantaro S, D'Angelo A, Davis PA, Manzato E, Crepaldi G.

J Hypertens. 1998 Jul;16(7):1001-8.

PMID:
9794741
12.

Hemoglobin-AGE: a circulating marker of advanced glycosylation.

Makita Z, Vlassara H, Rayfield E, Cartwright K, Friedman E, Rodby R, Cerami A, Bucala R.

Science. 1992 Oct 23;258(5082):651-3.

PMID:
1411574
13.
14.

Impact of concentrations of glycated hemoglobin, alpha-tocopherol, copper, and manganese on oxidation of low-density lipoproteins in patients with type I diabetes, type II diabetes and control subjects.

Leonhardt W, Hanefeld M, Müller G, Hora C, Meissner D, Lattke P, Paetzold A, Jaross W, Schroeder HE.

Clin Chim Acta. 1996 Oct 29;254(2):173-86.

PMID:
8896905
15.

Modification of proteins in vitro by physiological levels of glucose: pyridoxamine inhibits conversion of Amadori intermediate to advanced glycation end-products through binding of redox metal ions.

Voziyan PA, Khalifah RG, Thibaudeau C, Yildiz A, Jacob J, Serianni AS, Hudson BG.

J Biol Chem. 2003 Nov 21;278(47):46616-24. Epub 2003 Sep 15.

16.

In vivo glycated low-density lipoprotein is not more susceptible to oxidation than nonglycated low-density lipoprotein in type 1 diabetes.

Jenkins AJ, Thorpe SR, Alderson NL, Hermayer KL, Lyons TJ, King LP, Chassereau CN, Klein RL.

Metabolism. 2004 Aug;53(8):969-76.

PMID:
15281003
17.

LDL oxidative modifications in well- or moderately controlled type 2 diabetes.

Scheffer PG, Henry RM, Wever EJ, van Rooij GJ, Bos G, Heine RJ, Dekker JM, Diamant M, Stehouwer CD, Nijpels G, Blankenstein MA, Teerlink T.

Diabetes Metab Res Rev. 2004 Jul-Aug;20(4):298-304.

PMID:
15250032
18.

Carbonyl stress in the pathogenesis of diabetic nephropathy.

Suzuki D, Miyata T.

Intern Med. 1999 Apr;38(4):309-14. Review.

19.

Advanced glycosylated end products and hyperglycemia in the pathogenesis of diabetic complications.

Friedman EA.

Diabetes Care. 1999 Mar;22 Suppl 2:B65-71. Review.

PMID:
10097902
20.

Glycation and lipid peroxidation in children and adolescents with type 1 diabetes mellitus with and without diabetic complications.

Kostolanská J, Jakus V, Barák L.

J Pediatr Endocrinol Metab. 2009 Jul;22(7):635-43.

PMID:
19774845

Supplemental Content

Support Center